BRPI1015311A2 - método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processada - Google Patents
método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processadaInfo
- Publication number
- BRPI1015311A2 BRPI1015311A2 BRPI1015311A BRPI1015311A BRPI1015311A2 BR PI1015311 A2 BRPI1015311 A2 BR PI1015311A2 BR PI1015311 A BRPI1015311 A BR PI1015311A BR PI1015311 A BRPI1015311 A BR PI1015311A BR PI1015311 A2 BRPI1015311 A2 BR PI1015311A2
- Authority
- BR
- Brazil
- Prior art keywords
- processed
- neurotoxin polypeptide
- kit
- determining
- solution containing
- Prior art date
Links
- 101710138657 Neurotoxin Proteins 0.000 title 2
- 239000002581 neurotoxin Substances 0.000 title 2
- 231100000618 neurotoxin Toxicity 0.000 title 2
- 229920001184 polypeptide Polymers 0.000 title 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 2
- 108090000765 processed proteins & peptides Proteins 0.000 title 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21465009P | 2009-04-27 | 2009-04-27 | |
| EP09158788.1 | 2009-04-27 | ||
| US61/214,650 | 2009-04-27 | ||
| EP09158788 | 2009-04-27 | ||
| PCT/EP2010/055432 WO2010124998A1 (en) | 2009-04-27 | 2010-04-23 | Means and methods for the determination of the amount of neurotoxin polypeptide and of its catalytic and proteolytic activities |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI1015311A2 true BRPI1015311A2 (pt) | 2016-04-19 |
| BRPI1015311B1 BRPI1015311B1 (pt) | 2024-01-09 |
Family
ID=41066304
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1015311-0A BRPI1015311B1 (pt) | 2009-04-27 | 2010-04-23 | Método para determinar a quantidade de polipeptídeo de neurotoxina processada em uma solução, dispositivo para determinação da quantidade de polipeptídeo de neurotoxina processada contida em uma solução e kit adaptado |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US8663942B2 (pt) |
| EP (1) | EP2425251B1 (pt) |
| JP (1) | JP5689113B2 (pt) |
| KR (1) | KR101818777B1 (pt) |
| CN (1) | CN102414564B (pt) |
| AU (1) | AU2010243692B2 (pt) |
| BR (1) | BRPI1015311B1 (pt) |
| CA (1) | CA2757637C (pt) |
| ES (1) | ES2647243T3 (pt) |
| HK (1) | HK1169171A1 (pt) |
| IL (1) | IL215441A (pt) |
| MX (1) | MX2011011045A (pt) |
| PT (1) | PT2425251T (pt) |
| RU (1) | RU2545783C9 (pt) |
| WO (1) | WO2010124998A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2603518B1 (en) * | 2010-08-11 | 2015-06-17 | Merz Pharma GmbH & Co. KGaA | Selective manufacture of recombinant neurotoxin polypeptides |
| RU2673910C2 (ru) * | 2012-11-21 | 2018-12-03 | Ипсен Байоинновейшн Лимитед | Способ производства протеолитически процессированного полипептида |
| MX360513B (es) * | 2013-06-28 | 2018-11-07 | Merz Pharma Gmbh & Co Kgaa | Medios y metodos para la determinacion de la actividad biologica de polipeptidos de neurotoxina en celulas. |
| JP6682532B2 (ja) | 2014-11-21 | 2020-04-15 | メルツ ファルマ ゲーエムベーハー ウント コンパニー カーゲーアーアー | 神経毒ポリペプチドの生物学的活性を測定する方法 |
| RU2694964C2 (ru) * | 2017-12-19 | 2019-07-19 | ФЕДЕРАЛЬНОЕ АГЕНТСТВО ПО ТЕХНИЧЕСКОМУ РЕГУЛИРОВАНИЮ И МЕТРОЛОГИИ (Росстандарт) | Способ измерений каталитической активности (каталитической концентрации) ферментов с использованием методов масс-спектрометрии и спектрофотометрии с предварительной идентификацией целевого аналита и определением чистоты веществ |
| CN111801580B (zh) | 2018-01-12 | 2024-08-23 | 建新公司 | 用于定量多肽的方法 |
| JP2021533201A (ja) * | 2018-07-31 | 2021-12-02 | スノーレトックス プロプライエタリー リミテッド | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| WO2020206375A1 (en) * | 2019-04-03 | 2020-10-08 | Technical University Of Denmark | Neurotrophic factor protein conjugates and related embodiments |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4208479A (en) * | 1977-07-14 | 1980-06-17 | Syva Company | Label modified immunoassays |
| ATE189682T1 (de) * | 1989-08-16 | 2000-02-15 | Chiron Corp | Prohormonspaltungsplatzblockierungsantikörper |
| GB9411138D0 (en) * | 1994-06-03 | 1994-07-27 | Microbiological Res Authority | Toxin assay |
| EP1700918B1 (en) * | 1999-08-25 | 2014-01-15 | Allergan, Inc. | Activatable recombinant neurotoxins |
| US6678651B2 (en) * | 2000-09-15 | 2004-01-13 | Mindspeed Technologies, Inc. | Short-term enhancement in CELP speech coding |
| US7332567B2 (en) * | 2001-08-28 | 2008-02-19 | Allergan, Inc. | Fret protease assays for clostridial toxins |
| US20060063221A1 (en) * | 2004-09-21 | 2006-03-23 | Williams Dudley J | Lanthanide-based substrates and methods for determining clostridial toxin activity |
| EP2332959B1 (en) * | 2003-12-19 | 2014-11-26 | Wisconsin Alumni Research Foundation | Method and compositions for detecting botulinum neurotoxin |
| FR2869908B1 (fr) * | 2004-05-05 | 2006-07-28 | Pharmaleads | Substrat peptidique reconnu par la toxine botulique de type a, bont/a et son utilisation pour detecter et/ou doser ladite toxine ou des inhibiteurs de son activite |
| CA2686637A1 (en) * | 2007-06-01 | 2008-12-04 | Merz Pharma Gmbh & Co. Kgaa | Process for providing a temperature - stable muscle relaxant on the basis of the neurotoxic component of botulinum toxin in solid form |
| US7732579B2 (en) * | 2007-06-13 | 2010-06-08 | The United States Of America As Represented By The Secretary Of Agriculture | High-affinity monoclonal antibodies for botulinum toxin type A |
| EP2178905B1 (en) * | 2007-07-26 | 2013-11-06 | Allergan, Inc. | Methods of activiting clostridial toxins |
| CN101386648B (zh) * | 2008-09-25 | 2012-05-30 | 中国人民解放军军事医学科学院微生物流行病研究所 | 抗b型肉毒神经毒素中和性单克隆抗体、其制备方法及用途 |
| MX340772B (es) * | 2009-02-19 | 2016-07-26 | Merz Pharma Gmbh & Co Kgaa | Medios y metodos para fabricar neurotoxina altamente pura. |
-
2010
- 2010-04-23 CN CN201080018544.0A patent/CN102414564B/zh active Active
- 2010-04-23 MX MX2011011045A patent/MX2011011045A/es active IP Right Grant
- 2010-04-23 AU AU2010243692A patent/AU2010243692B2/en active Active
- 2010-04-23 PT PT107140378T patent/PT2425251T/pt unknown
- 2010-04-23 EP EP10714037.8A patent/EP2425251B1/en active Active
- 2010-04-23 US US13/138,948 patent/US8663942B2/en active Active
- 2010-04-23 RU RU2011147994/15A patent/RU2545783C9/ru active
- 2010-04-23 ES ES10714037.8T patent/ES2647243T3/es active Active
- 2010-04-23 JP JP2012506517A patent/JP5689113B2/ja active Active
- 2010-04-23 KR KR1020117028244A patent/KR101818777B1/ko active IP Right Grant
- 2010-04-23 CA CA2757637A patent/CA2757637C/en active Active
- 2010-04-23 WO PCT/EP2010/055432 patent/WO2010124998A1/en active Application Filing
- 2010-04-23 BR BRPI1015311-0A patent/BRPI1015311B1/pt active IP Right Grant
-
2011
- 2011-09-27 IL IL215441A patent/IL215441A/en active IP Right Grant
-
2012
- 2012-10-10 HK HK12109957.8A patent/HK1169171A1/xx unknown
-
2014
- 2014-01-16 US US14/157,046 patent/US20140134643A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| RU2545783C9 (ru) | 2016-02-27 |
| KR101818777B1 (ko) | 2018-01-15 |
| US8663942B2 (en) | 2014-03-04 |
| PT2425251T (pt) | 2017-11-27 |
| JP2012525563A (ja) | 2012-10-22 |
| WO2010124998A1 (en) | 2010-11-04 |
| ES2647243T3 (es) | 2017-12-20 |
| EP2425251A1 (en) | 2012-03-07 |
| RU2545783C2 (ru) | 2015-04-10 |
| US20140134643A1 (en) | 2014-05-15 |
| CA2757637A1 (en) | 2010-11-04 |
| AU2010243692A1 (en) | 2011-10-27 |
| IL215441A (en) | 2015-04-30 |
| RU2011147994A (ru) | 2013-06-10 |
| CN102414564A (zh) | 2012-04-11 |
| IL215441A0 (en) | 2011-12-29 |
| BRPI1015311B1 (pt) | 2024-01-09 |
| JP5689113B2 (ja) | 2015-03-25 |
| US20120142024A1 (en) | 2012-06-07 |
| MX2011011045A (es) | 2011-11-04 |
| KR20120005041A (ko) | 2012-01-13 |
| AU2010243692B2 (en) | 2015-03-05 |
| HK1169171A1 (en) | 2013-01-18 |
| EP2425251B1 (en) | 2017-10-25 |
| CA2757637C (en) | 2017-10-24 |
| CN102414564B (zh) | 2015-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1015311A2 (pt) | método, dispositivo e kit para determinar a quantidade de polipetídeo de neurotoxina processada e processada ativa em uma solução contendo polipeptídeo de neurotoxina processada e parcialmente processada e/ou não processada | |
| BR112012029897A2 (pt) | método para reduzir a quantidade de uma serina protease ou um zimogênio de serina protease em uma composição, método para preparar uma composição, composição de proteína derivada de plasma, e, método para tratamento de uma doença | |
| HRP20181989T1 (hr) | Sredstva za i postupci određivanja biološke aktivnosti neurotoksičnih polipeptida u stanicama | |
| BR112012002140A2 (pt) | métodos para purificar recombinante a tipo desintegrina e metalopeptidase com proteína trombospondina e para inativar contaminantes de vírus em uma amostra de proteína,e, composição. | |
| BRPI1011886A2 (pt) | solução contendo ácido hiplocloroso e métodos do uso do mesmo. | |
| BRPI1015026A2 (pt) | método e aparelho para facilitar os procedimentos de medição em operação de multiportadora. | |
| EE200900072A (et) | Territooriumi ja selle perimeetri jälgimise süsteem ja meetod | |
| BRPI1007477A2 (pt) | método, e, composição de tratamento de poço | |
| BR112014010162A8 (pt) | uso de composição, método para melhorar o reconhecimento e/ou tratar ou prevenir função de reconhecimento prejudicada em um indivíduo, e composição | |
| BR112012002137A2 (pt) | método para um polipeptídeo e/ou vírus de interesse em uma cultura de célula contínua,e, composição | |
| BRPI0914824A2 (pt) | produção de proteína melhorada e armazenagem em plantas | |
| BRPI1006145A2 (pt) | "composição e método para tratamento de diabetes". | |
| BR112013015527A2 (pt) | implante crestal e método para o seu processamento | |
| BRPI0923290A2 (pt) | métodos para remover acrilamida em uma massa aquosa de fluido, e para remover acrilamida em um fluido aquoso de tratamento de poço, e, composição aquosa de fluido para tratamento de poço. | |
| BRPI1013965A2 (pt) | sistema de moagem e método de moagem. | |
| FI20085409A0 (fi) | Menetelmä ja laite viestien käsittelemiseksi | |
| BR112013015453A2 (pt) | composição não-espumante e método para o tratamento não-terapêutico das matérias queratínicas | |
| BRPI0906438A2 (pt) | Isolamento de conteúdo por meio de processos em uma aplicação | |
| EP2527671A4 (en) | TORQUE COMPENSATION PROCEDURE FOR A FOUR-POINT CONTACT BALL BEARING AND CALCULATION DEVICE AND CALCULATION PROGRAM THEREFOR | |
| BR112012005140A2 (pt) | inibidores de hsl úteis no tratamento de diabetes | |
| EP2410337A4 (en) | PROCESS FOR BETA-GLUCAN MEASUREMENT AND BETA-GLUCAN BINDING PROTEIN FOR USE IN THIS METHOD | |
| BR112014000219A2 (pt) | dispositivo de ensaio para a detecção de uma enzima ativa em uma amostra, método de determinação de presença e dos níveis de uma enzima ativa em uma amostra, kit, dispositivo de ensaio, ou método de uso ou o uso do mesmo e uso | |
| BRPI0914933A2 (pt) | Composições e métodos para níveis de aminoácido aumentados em plantas | |
| BR112016011046A2 (pt) | método para genotipagem, método para a detecção de uma infecção, kit para detectar uma infecção e método para detectar em uma amostra biológica. | |
| BR112014002566A2 (pt) | método para tratar resíduo, e, dispositivo para o tratamento mecânico ou mecânico-biológico de resíduo. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/04/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |